Exploring inflammation in hemodialysis patients: Persistent and superimposed inflammation - A longitudinal study

Kidney and Blood Pressure Research

Volumn 27, Issue 2, 2004, Pages 63-70

  Tsirpanlis, George ^a,e   Bagos, Pantelis ^b   Ioannou, Dimitris ^c   Bleta, Aliki ^c   Marinou, Ioanna ^d   Lagouranis, Antonis ^a   Chatzipanagiotou, Stylianos ^d   Nicolaou, Chrysoula ^d  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Dragini Clinic   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e NONE   (Greece)

Author keywords

C reactive protein; Cardiovascular risk; Interleukin 6; Microinflammation; Serum amyloid A

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 6; PREGNANCY ASSOCIATED PROTEIN; SERUM AMYLOID A;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; MEASUREMENT; MORBIDITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SERUM AMYLOID A PROTEIN;

EID: 2342562986     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075809     Document Type: Article

References (27)

1. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
2. Yeun JY, Levine RA, Martadilak V, Kaysen GA: C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476.
3. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002;17:1684-1688.
4. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW: The acute phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 2000;58:346-352.
5. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.
6. Arici M, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing ling? Kidney Int 2001;59:407-414.
7. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Triperi G, Malatino L, Zoccali C: Inflammation and outcome in endstage renal failure: Does female gender constitute a survival advantage? Kidney Int 2002;62:1791-1798.
8. van Tellingen A, Grooteman M, Schoorl M, Bartels P, Schoorl M, van der Ploeg T, Wee PM, Nube MJ: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 2002;62:632-638.
9. Beerenhout CH, Kooman JP, van der Sande FM, Hackeng C, Leunissen KML: C-reactive protein levels in dialysis patients are highly variable and strongly related to co-morbidity (letter). Nephrol Dial Transplant 2003;18:22.
10. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362.
11. Armitage P, Berry G: Statistical Methods in Medical Research, ed 3. London, Blackwell, 1994.
12. Dunn G: Analysis of variance for longitudinal data; in Armitage P, Colton T (eds): Encyclopedia of Biostatistics. Chichester, Wiley, 1998, pp 161-165.
13. Box GEP: Some theorems on quadratic forms applied in the study of analysis of variance. II. Effects of inequality of variance and of correlation between errors in the two-way classification. Ann Math Stat 1954;25:484-498.
14. Greenhouse SW, Geisser S: On the methods in the analysis of profile data. Psychometrika 1959;24:95-112.
15. Huynh H, Feldt LS: Estimation of the Box correction for degrees of freedom for sample data in randomized and split-plot designs. J Educ Statist 1976;1:69-82.
16. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
17. Pearson TA, Mensah GA, Wayne Alexander R, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice. Circulation 2003;107:499-511.
18. Ockene IR, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E: Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001;47:444-450.
19. McIntyre C, Harper I, Macdougall IC, Raine AEG, Williams A, Baker LRI: Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol 1997;48:371-374.
20. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C: The variability and accurate assessment of the microinflammation in hemodialysis patients. Nephrol Dial Transplant 2004;19:150-157.
21. 2 concentrations: A placebo-controlled study using a hs-CRP. J Am Coll Cardiol 2001;37:2036-2041.
22. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP: Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 2001;154:681-689.
23. Rahmati MA, Craig RG, Homel P, Kaysen GA, Levin NW: Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis 2002;40:983-989.
24. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M: Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001;16:335-340.
25. Gordon C: Long-term complications of systemic lupus erythematosus. Rheumatology 2002;41:1095-1100.
26. Verma S, Wang C-H, Li S-H, Dumont AS, Fedak PWM, Badiwala MV, Dhillon B, Weisel RD, Li R-K, Mickle DAG, Stewart DJ: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-919.
27. Wang C-H, Li S-H, Weisel RD, Fedak PWM, Dumont AS, Szmitko P, Li R-K, Mickle DAG, Verma S: C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003;107:1783-1790.